Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1600
+0.0050 (3.23%)
Jul 21, 2026, 12:51 PM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 16.88 million as of July 21, 2026. Its market cap has increased by 57.69% in one year.
Market Cap
16.88M
Enterprise Value
16.30M
Revenue
889.57K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
ChartMarket Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 16.88M, an increase of 154.18%. That is a compound annual growth rate of 22.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 16.88M | 40.91% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thiogenesis Therapeutics | 29.55M |
| Quantum BioPharma | 28.79M |
| Lobe Sciences | 28.41M |
| Sharp Therapeutics | 27.37M |
| Alzai Health | 25.02M |
| Devonian Health Group | 19.49M |
| Rapid Dose Therapeutics | 14.33M |
| Hemostemix | 12.86M |